As the stemness of cancer cells is a major cause of drug resistance (Shen, 2022), both bioinformatics analysis (Figure 3F) and IC50 value detection (Figure 3G) exhibited that FLRT2 abrogates NSCLC cells cisplatin resistance. The gene discussed is FLRT2; the disease is cancer.